AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11994796 — intervention group
Group type: COMPARATOR
Intervention: Suprascapular nerve block using needle tip guided by superficial bony landmarks
Number of subjects: 41
Study 9661563 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuffed oropharyngeal airway (COPA)
Number of subjects: 40
Study 9661563 — intervention group
Group type: COMPARATOR
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 40
Study 7661335 — intervention group
Group type: EXPERIMENTAL
Intervention: HHL (10% hydroxyethylstarch 200/0.5 in 7.2% saline)
Number of subjects: 21
Study 7661335 — intervention group
Group type: COMPARATOR
Intervention: HA (5% albumin)
Number of subjects: 21
Study 7661335 — intervention group
Group type: COMPARATOR
Intervention: HES (6% hydroxyethylstarch in 0.9% saline)
Number of subjects: 21
Study 2698394 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate infusion in MVA patients
Number of subjects: 30
Study 2698394 — intervention group
Group type: COMPARATOR
Intervention: MVA patients
Number of subjects: 30
Study 128498 — intervention group
Group type: EXPERIMENTAL
Intervention: Iotroxamid (Chologram)
Number of subjects: 0
Study 128498 — intervention group
Group type: COMPARATOR
Intervention: Ioglycamid (Bilivistan)
Number of subjects: 0
Study 6784976 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine 7.5 mg daily
Number of subjects: 10
Study 6784976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31711489 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncomplicated malaria
Number of subjects: 1373
Study 31711489 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe malaria
Number of subjects: 1373
Study 31711489 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncomplicated malaria (children under five)
Number of subjects: 1373
Study 31711489 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe malaria (children under five)
Number of subjects: 1373
Study 31711489 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncomplicated malaria (health system costs)
Number of subjects: 1373
Study 31711489 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe malaria (health system costs)
Number of subjects: 1373
Study 31711489 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cost of malaria care to society
Number of subjects: 1373
Study 28298031 — intervention group
Group type: EXPERIMENTAL
Intervention: Clipping
Number of subjects: 362
Study 28298031 — intervention group
Group type: COMPARATOR
Intervention: Coiling
Number of subjects: 362
Study 28298031 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Clipping and Coiling
Number of subjects: 362
Study 27018305 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted Cycling Therapy (ACT)
Number of subjects: 44
Study 27018305 — intervention group
Group type: COMPARATOR
Intervention: Voluntary Cycling (VC)
Number of subjects: 44
Study 25935960 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopy-laparoscopy
Number of subjects: 200
Study 25935960 — intervention group
Group type: COMPARATOR
Intervention: Folic acid 5 mg/day (Control)
Number of subjects: 200
Study 22420866 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin infusion
Number of subjects: 26
Study 22420866 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 26
Study 20813019 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented training with trunk restraint
Number of subjects: 12
Study 20813019 — intervention group
Group type: COMPARATOR
Intervention: Task-oriented training without trunk restraint
Number of subjects: 12
Study 17605536 — intervention group
Group type: EXPERIMENTAL
Intervention: Community‐university partnership model for recruitment
Number of subjects: 14
Study 17605536 — intervention group
Group type: EXPERIMENTAL
Intervention: Community team functioning and technical assistance variables
Number of subjects: 14
Study 16046381 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal therapy (60 degrees C far-infrared ray dry sauna for 15 minutes, followed by bed rest with a blanket for 30 minutes, once a day, 5 days a week for 20 sessions in 4 weeks)
Number of subjects: 28
Study 16046381 — intervention group
Group type: COMPARATOR
Intervention: Nonthermal therapy (control group)
Number of subjects: 28
Study 12500883 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline summary, performance feedback, and medical chart reminders
Number of subjects: 1189
Study 12500883 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 1189
Study 9860109 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg administered orally at 0700 and 1600 hours on days 3, 4, and 5)
Number of subjects: 43
Study 9860109 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 7895560 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (6.25 mg/hr continuous infusion)
Number of subjects: 34
Study 7895560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 2715089 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.15 mg/kg
Number of subjects: 11
Study 2715089 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.3 mg/kg
Number of subjects: 11
Study 2715089 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.5 mg/kg
Number of subjects: 11
Study 2715089 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 23489 — intervention group
Group type: EXPERIMENTAL
Intervention: Clorazepate (15 mg at night)
Number of subjects: 54
Study 23489 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (5 mg three times a day)
Number of subjects: 54
Study 29262751 — intervention group
Group type: EXPERIMENTAL
Intervention: High compression pressure >45 mmHg
Number of subjects: 102
Study 29262751 — intervention group
Group type: COMPARATOR
Intervention: Moderate compression pressure 35-40 mmHg
Number of subjects: 102
Study 27842548 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate complete revascularization (CR)
Number of subjects: 93
Study 27842548 — intervention group
Group type: COMPARATOR
Intervention: Staged complete revascularization (CR)
Number of subjects: 93
Study 25037854 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) concentrations <8 mg/l
Number of subjects: 312
Study 25037854 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) concentrations 8-19 mg/l
Number of subjects: 312
Study 25037854 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) concentrations >20 mg/l
Number of subjects: 312
Study 25037854 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 312
Study 22643937 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine spray
Number of subjects: 62
Study 22643937 — intervention group
Group type: COMPARATOR
Intervention: Levobupivacaine solution
Number of subjects: 62
Study 19897236 — intervention group
Group type: EXPERIMENTAL
Intervention: Early sexual debut (first heterosexual intercourse)
Number of subjects: 5131
Study 19256180 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients treated for hypertension
Number of subjects: 1763
Study 19256180 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with blood pressure below goal
Number of subjects: 1763
Study 19256180 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 1763
Study 19256180 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals treated by a solo provider
Number of subjects: 1763
Study 19256180 — intervention group
Group type: EXPERIMENTAL
Intervention: Undiagnosed hypertension
Number of subjects: 1763
Study 19256180 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosed hypertension
Number of subjects: 1763
Study 16200335 — intervention group
Group type: COMPARATOR
Intervention: Rosiglitazone (4 mg/day)
Number of subjects: 90
Study 16200335 — intervention group
Group type: COMPARATOR
Intervention: Metformin (1 g/day)
Number of subjects: 90
Study 16200335 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 90
Study 15600197 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (rhGH)
Number of subjects: 60
Study 15600197 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rhGH)
Number of subjects: 60
Study 10801179 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine
Number of subjects: 0
Study 10801179 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirits
Number of subjects: 0
Study 10801179 — intervention group
Group type: COMPARATOR
Intervention: Beer
Number of subjects: 0
Study 8991488 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-462 IV doses of 5-90 micrograms kg-1
Number of subjects: 12
Study 8991488 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-462 IV doses of 60-90 micrograms kg-1
Number of subjects: 12
Study 8991488 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-462 oral 40 mg tablet without breakfast
Number of subjects: 12
Study 8991488 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-462 oral 40 mg tablet with standard breakfast
Number of subjects: 12
Study 1481177 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen at 2 l/min
Number of subjects: 30
Study 1481177 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen at 4 l/min
Number of subjects: 30
Study 1481177 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen at 6 l/min
Number of subjects: 30
Study 3922282 — intervention group
Group type: EXPERIMENTAL
Intervention: gamma-vinyl GABA
Number of subjects: 21
Study 3922282 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 28631423 — intervention group
Group type: EXPERIMENTAL
Intervention: Pet ownership
Number of subjects: 0
Study 27793125 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month telephone-delivered weight loss intervention targeting diet and physical activity
Number of subjects: 156
Study 27793125 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 156
Study 24931591 — intervention group
Group type: EXPERIMENTAL
Intervention: Fio2 of 0.14 to 0.15 (average target altitude 3043 m)
Number of subjects: 76
Study 24931591 — intervention group
Group type: COMPARATOR
Intervention: Control group with Fio2 of 0.209
Number of subjects: 76
Study 21904248 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 25
Study 21904248 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 25
Study 21904248 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 25
Study 20434051 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracerebral hemorrhage (ICH)
Number of subjects: 1604
Study 20434051 — intervention group
Group type: COMPARATOR
Intervention: Ischemic stroke
Number of subjects: 1604
Study 18695809 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid petroleum jelly (30 ml applied in the perineal region during the expulsive period)
Number of subjects: 38
Study 18695809 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 38
Study 18695809 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid petroleum jelly
Number of subjects: 38
Study 15991506 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil with a small dose of piritramide (0.1 mg kg(‐1))
Number of subjects: 40
Study 15991506 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl-based protocol
Number of subjects: 40
Study 12027845 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 16 mg
Number of subjects: 179
Study 12027845 — intervention group
Group type: EXPERIMENTAL
Intervention: tropisetron 5 mg
Number of subjects: 179
Study 12027845 — intervention group
Group type: COMPARATOR
Intervention: metoclopramide 10 mg
Number of subjects: 179
Study 10464529 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline group (HSG)
Number of subjects: 50
Study 10464529 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline group (ISG)
Number of subjects: 50
Study 8815566 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) nadroparin with graduated compression stockings
Number of subjects: 241
Study 8815566 — intervention group
Group type: COMPARATOR
Intervention: Graduated compression stockings alone (Control)
Number of subjects: 241
Study 1867297 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 56
Study 1867297 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 56
Study 6618119 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 40
Study 6618119 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 40
Study 30696483 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg ixekizumab every 4 weeks (IXEQ4W)
Number of subjects: 679
Study 30696483 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg ixekizumab every 2 weeks (IXEQ2W)
Number of subjects: 679
Study 30696483 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 679
Study 30696483 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who resolved enthesitis
Number of subjects: 679
Study 30696483 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who did not resolve enthesitis
Number of subjects: 679
Study 30696483 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who resolved dactylitis
Number of subjects: 679
Study 30696483 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who did not resolve dactylitis
Number of subjects: 679
Study 28266821 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxapine (50 mg daily for 4 weeks)
Number of subjects: 26
Study 28266821 — intervention group
Group type: COMPARATOR
Intervention: Vitamin B12 (500 μg three-times daily for 4 weeks)
Number of subjects: 26
Study 26344392 — intervention group
Group type: EXPERIMENTAL
Intervention: High FIS therapists
Number of subjects: 65
Study 26344392 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FIS therapists
Number of subjects: 65
Study 26344392 — intervention group
Group type: EXPERIMENTAL
Intervention: All clients treated by therapists
Number of subjects: 65
Study 26344392 — intervention group
Group type: COMPARATOR
Intervention: Silent control group
Number of subjects: 65
Study 24912615 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopically-assisted selective neck dissection (SND)
Number of subjects: 44
Study 24912615 — intervention group
Group type: COMPARATOR
Intervention: Conventional selective neck dissection (SND)
Number of subjects: 44
Study 22836352 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerecyte coils
Number of subjects: 500
Study 22836352 — intervention group
Group type: COMPARATOR
Intervention: Bare platinum coils
Number of subjects: 500
Study 19673086 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency (HF) rTMS over the left DLPFC
Number of subjects: 16
Study 19673086 — intervention group
Group type: COMPARATOR
Intervention: Placebo rTMS over the left DLPFC
Number of subjects: 16
Study 17619558 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg
Number of subjects: 1365
Study 17619558 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 1365
Study 17619558 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1365
Study 15757012 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Treadmill Testing (ETT)
Number of subjects: 212
Study 15757012 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress Imaging
Number of subjects: 212
Study 15757012 — intervention group
Group type: COMPARATOR
Intervention: Routine Hospital Admission
Number of subjects: 212
Study 12081816 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground beef with 2.7 g of phytosterols
Number of subjects: 34
Study 12081816 — intervention group
Group type: COMPARATOR
Intervention: Ground beef alone (control)
Number of subjects: 34
Study 9607230 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-by-step training with feedback, using role-play and video-recording (experimental)
Number of subjects: 20
Study 9607230 — intervention group
Group type: COMPARATOR
Intervention: Self-administered teaching programme (self-training)
Number of subjects: 20
Study 7634863 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic drainage (TD)
Number of subjects: 61
Study 7634863 — intervention group
Group type: COMPARATOR
Intervention: Needle aspiration (NA)
Number of subjects: 61
Study 7634863 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate needle aspiration (NA)
Number of subjects: 61
Study 1495689 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg
Number of subjects: 8
Study 1495689 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 6431853 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn sodium
Number of subjects: 27
Study 6431853 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 30702374 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO mouth rinse (maltodextrin, 6%)
Number of subjects: 10
Study 30702374 — intervention group
Group type: COMPARATOR
Intervention: Placebo (industrialized noncaloric juice with the same taste)
Number of subjects: 10
Study 29530346 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery with intraperitoneal chemotherapy (CRS + IPC)
Number of subjects: 0
Study 29530346 — intervention group
Group type: COMPARATOR
Intervention: Systemic chemotherapy
Number of subjects: 0
Study 27649961 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) at 660 nm, spatial average energy fluency (SAEF) = 1.06 J/cm2, applied on postoperative days 2, 4, 6, and 8.
Number of subjects: 90
Study 27649961 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (details not specified).
Number of subjects: 90
Study 27649961 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 90
Study 24315980 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 12 weeks, two supervised and one self-instructed session per week.
Number of subjects: 0
Study 24315980 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training for 12 weeks, two supervised and one self-instructed session per week.
Number of subjects: 0
Study 24315980 — intervention group
Group type: COMPARATOR
Intervention: Control group without specific physical training, receiving respiratory therapy over 12 weeks.
Number of subjects: 0
Study 22475741 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized fluticasone 880 μg twice daily for 6 weeks
Number of subjects: 42
Study 22475741 — intervention group
Group type: COMPARATOR
Intervention: Placebo inhaler twice daily for 6 weeks
Number of subjects: 42
Study 20576092 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of methotrexate, sulfasalazine, and hydroxychloroquine with prednisolone (FIN‐RACo)
Number of subjects: 199
Study 20576092 — intervention group
Group type: COMPARATOR
Intervention: Single DMARD (initially, sulfasalazine) with or without prednisolone (SINGLE)
Number of subjects: 199
Study 17611823 — intervention group
Group type: EXPERIMENTAL
Intervention: Written educational material
Number of subjects: 378
Study 17611823 — intervention group
Group type: COMPARATOR
Intervention: Placebo material (2 leaflets about childproofing the house)
Number of subjects: 378
Study 15629211 — intervention group
Group type: EXPERIMENTAL
Intervention: Covert visual attention task for adults with dyslexia
Number of subjects: 0
Study 12406334 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg pimecrolimus twice daily
Number of subjects: 0
Study 12406334 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg pimecrolimus twice daily
Number of subjects: 0
Study 12406334 — intervention group
Group type: COMPARATOR
Intervention: pimecrolimus
Number of subjects: 0
Study 9411958 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive home visits by health care personnel
Number of subjects: 12
Study 9411958 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12
Study 8217026 — intervention group
Group type: EXPERIMENTAL
Intervention: lisinopril or isradipine
Number of subjects: 30
Study 8217026 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 3121861 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion hydrochloride, 225-450 mg/day
Number of subjects: 60
Study 3121861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 3121861 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion hydrochloride
Number of subjects: 60
Study 29700636 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with hematopoietic stem cell rescue, modified regimen including melphalan, carboplatin, and etoposide.
Number of subjects: 50
Study 29700636 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (initial regimen before modification).
Number of subjects: 50
Study 29700636 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified high-dose chemotherapy regimen.
Number of subjects: 50
Study 29700636 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients younger than 547 days and those with whole chromosomal gains/losses pattern.
Number of subjects: 50
Study 29700636 — intervention group
Group type: EXPERIMENTAL
Intervention: MYCN amplification cases.
Number of subjects: 50
Study 27377612 — intervention group
Group type: EXPERIMENTAL
Intervention: Local wound care interventions (specific interventions not detailed)
Number of subjects: 0
Study 27377612 — intervention group
Group type: COMPARATOR
Intervention: Cochrane review findings
Number of subjects: 0
Study 24925270 — intervention group
Group type: EXPERIMENTAL
Intervention: MD supplemented with 50mL/d of extra virgin olive oil (MD+EVOO)
Number of subjects: 164
Study 24925270 — intervention group
Group type: EXPERIMENTAL
Intervention: MD supplemented with 30 g/d of nuts (MD+Nuts)
Number of subjects: 164
Study 24925270 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 164
Study 23218622 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive approach (group A)
Number of subjects: 40
Study 23218622 — intervention group
Group type: COMPARATOR
Intervention: Conventional anterolateral approach (group B)
Number of subjects: 40
Study 20724431 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. cyclophosphamide (CYC) 0.5 g/m2 at 4-week intervals with low-dose prednisolone
Number of subjects: 12
Study 20724431 — intervention group
Group type: COMPARATOR
Intervention: Low-dose prednisolone alone
Number of subjects: 12